International Clinical Trial: Prospective, Single-Arm, Phase ? Clinical Study of Nimotuzumab Combined with Chemotherapy as Neoadjuvant Therapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126570) titled 'Prospective, Single-Arm, Phase ? Clinical Study of Nimotuzumab Combined with Chemotherapy as Neoadjuvant Therapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma' on June 11.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Department of Oncology, the Sixth Medical Center of PLA General Hospital, Beijing, China

Condition: Locally Advanced Head and Neck Squamous Cell Carcinoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-07-01

Target Sample Size: Single arm:42;

Countries of Recruitment: China

To know more, visit https://w...